دراسة مقارنة 40 60 80 و 90 مليون من الخلايا الجذعية الوسيطة في علاج تليف الكبد
This analytical study compares the efficacy of 40, 60, 80, و 90 million mesenchymal stem cells (اللجان الدائمة) in treating liver cirrhosis. Results reveal significant differences in treatment response across MSC dosages, offering crucial insights for optimizing cell-based therapies. Read the full study for detailed findings.




